Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 1c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: CTKB) | Delayed: 5.95 -0.01 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.96 | 52 Week High | $ | |||
| Open | $6.00 | 52 Week Low | $ | |||
| Day High | $6.09 | P/E | N/A | |||
| Day Low | $5.85 | EPS | $ | |||
| Volume | 296,013 | |||||
